EP3197429
COMBINATION TREATMENT OF SGLT2 INHIBITORS AND DOPAMINE AGONISTS FOR PREVENTING METABOLIC DISORDERS IN EQUINE ANIMALS
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.9.2015:
22.5.2024:
15774881.5
:
21.9.2035
:
COMBINATION TREATMENT OF SGLT2 INHIBITORS AND DOPAMINE AGONISTS FOR PREVENTING METABOLIC DISORDERS IN EQUINE ANIMALS
22.9.2015
22.5.2024
:
Boehringer Ingelheim Vetmedica GmbH:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
:
REICHE, Dania Birte:
55216 Ingelheim am Rhein, DE
:
RAHMEL, Daniela:
55216 Ingelheim am Rhein, DE
:
14186479:
25.9.2014:
EP
:
EP2015071637:
22.9.2015
:
A61K 9/00, A61K 31/4045, A61K 31/428, A61K 31/48, A61K 31/506, A61K 31/70, A61K 31/7034, A61K 31/7042, A61K 31/7048, A61K 31/7056, A61P 3/10, A61P 9/12, A61P 1/14, A61P 1/16, A61P 43/00